Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Berry

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Pain|July 28, 2004
Complex regional pain syndrome-like symptoms during herpes zosterJames D Berry, Michael C Rowbotham, Karin Lottrup Petersen
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 5, 2014
Predicting success: optimizing phase II ALS trials for the transition to phase IIIJames D Berry, Merit E Cudkowicz, Jeremy M Shefner
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 22, 2015
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?Katharine A Nicholson, Merit E Cudkowicz, James D Berry
Muscle & Nerve|October 25, 2023
Identifying amyotrophic lateral sclerosis through interactions with an internet search engineElad Yom-Tov, Indu Navar, Ernest Fraenkel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 26, 2020
Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker studyJames D Berry, Richard Bedlack, Debra Mathews, et al.
Journal of Comparative Effectiveness Research|January 21, 2025
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysisJames D Berry, Melissa Hagan, Jeffrey Zhang, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|November 2, 2018
Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral SclerosisKaila L Stipancic, Yana Yunusova, James D Berry, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 14, 2024
Effects of COVID-19 on motor neuron disease mortality in the United States: a population-based cross-sectional studyJaime Raymond, James D Berry, Theodore Larson, et al.
Muscle & Nerve|May 17, 2020
Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trialsRaghav Govindarajan, James D Berry, Sabrina Paganoni, et al.
Muscle & Nerve|June 8, 2019
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one centerKate Brizzi, Sabrina Paganoni, April Zehm, et al.
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Pain|July 28, 2004
Complex regional pain syndrome-like symptoms during herpes zosterJames D Berry, Michael C Rowbotham, Karin Lottrup Petersen
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 5, 2014
Predicting success: optimizing phase II ALS trials for the transition to phase IIIJames D Berry, Merit E Cudkowicz, Jeremy M Shefner
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 22, 2015
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?Katharine A Nicholson, Merit E Cudkowicz, James D Berry
Muscle & Nerve|October 25, 2023
Identifying amyotrophic lateral sclerosis through interactions with an internet search engineElad Yom-Tov, Indu Navar, Ernest Fraenkel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 26, 2020
Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker studyJames D Berry, Richard Bedlack, Debra Mathews, et al.
Journal of Comparative Effectiveness Research|January 21, 2025
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysisJames D Berry, Melissa Hagan, Jeffrey Zhang, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|November 2, 2018
Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral SclerosisKaila L Stipancic, Yana Yunusova, James D Berry, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 14, 2024
Effects of COVID-19 on motor neuron disease mortality in the United States: a population-based cross-sectional studyJaime Raymond, James D Berry, Theodore Larson, et al.
Muscle & Nerve|May 17, 2020
Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trialsRaghav Govindarajan, James D Berry, Sabrina Paganoni, et al.
Muscle & Nerve|June 8, 2019
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one centerKate Brizzi, Sabrina Paganoni, April Zehm, et al.
Pageof 18